SFR-9350

N/A

Report date: 2025/01/26 15:10:18

Base Information

Drug NameSFR-9350
Drug Alias NameRecombinant human serum albumin-urate oxidase fusion protein (Tianjin Linda Biotechnology)rHSA-UOSFR-9350
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUric acid modulatorsUric acid stimulants
TargetsUric acid
Therapy Area/IndicationsGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Linda Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Linda Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A